Oxford Cannabinoid Technologies Ltd to IPO in London to fund development of
It plans to use the funds to help develop a portfolio of drug candidates for approval as licensed pain medicines…
Read More...
Read More...
Subscribe to our mailing list and get interesting stuff and updates to your email inbox.
Thank you for subscribing.
Something went wrong.
We respect your privacy and take protecting it seriously
Recover your password.
A password will be e-mailed to you.